news aktuell GmbH

GEMA is the first collecting society worldwide to file a lawsuit against a provider of generative artificial intelligence (AI) systems for the unlicensed use of protected musical works. Specifically, it concerns the US company OpenAI, the autogenerative chatbot systems operator. GEMA accuses OpenAI of reproducing protected song lyrics by German authors without having acquired licenses or paid the authors in question. The aim is to prove that OpenAI systematically uses GEMA's repertoire to train its systems.

Incoming orders after six months above previous year’s level thanks to strong drupa orders High order backlog provides sound basis for projected sales volume in second half of the year, capacities being fully utilized Strong seasonality in financial year, with sales and EBITDA in the first half of the year within expectations Packaging solutions segment remains growth driver Annual forecast confirmed

Strategic invests in Australia, New Zealand, Malaysia and Singapore

The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures per year in the U.S.[2] QUTENZA® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Topline results are expected in Q4 2025 and Averitas Pharma aims to submit a supplemental new drug application (sNDA) for a US label extension in 2026, subject to positive data.

The European Institute of Innovation and Technology (EIT) invites you to celebrate women entrepreneurs driving innovation and investment in Europe. The EIT Community will be hosting the INNOVEIT Conference which will feature industry leaders like Inga Grieger, Katarzyna Piasecki and Laura Wirsztel. A pitch session will showcase pioneering women-led ventures shaping the future of technology. Exclusive insights: Conference attendees will gain access to the latest research findings from the study “Women founders in European deep tech startups” by the initiative EIT Supernovas, revealing women’s impact in deep tech and the launch of the new Data Room which enhances visibility for women-led startups and scaleups by connecting them with potential investors.

20 years of applied digitalization and 5 years of experience with AI HEIDELBERG has been networking machines and systems in print shops since 2004 13,000 units worldwide are connected to the HEIDELBERG Cloud Three-digit million euro amount for digital processes, products and services

31.10.2024 – Köln (ots) | The competition for the European CIVIS Media Prize is on. Until 12 December 2024, media professionals from all EU countries and Switzerland can submit entries online on the topics of migration, integration, cultural diversity and related issues of social cohesion. The CIVIS Media Prize honours outstanding achievements in television, radio, internet and social media that promote the peaceful coexistence of people from different geographical and cultural backgrounds. It is endowed with a total of 27,000 euros. Nine CIVIS AWARDS are awarded in various categories. Further information on the CIVIS Media Prize 2025 can be found here. Click here to register. The CIVIS Media Prize is sponsored by ARD, represented by WDR, together with the Freudenberg Foundation. ORF, SRG SSR, ARTE, 3sat, Deutsche Welle, Deutschlandradio and EBU are media partners. WDR mediagroup, the Allianz Deutscher Produzentinnen und Produzenten – Film, TV und Audiovisuelle Medien e.V., the Verwert

The acquisition solidifies eM Client’s position as a leading email client provider, bringing its innovative solutions to a growing audience. Prague, October 23, 2024 – eM Client, a leading provider of email client software, announced its acquisition of Postbox Inc., a well-established email application company based in the United States. This acquisition enables eM Client to extend its innovative solutions to an even larger global audience, reinforcing its position as one of the most comprehensive email platforms available. Summary: Who: eM Client has acquired Postbox Inc. What: The acquisition expands eM Client’s reach to a broader user base. When: October 22, 2024. Where: eM Client is based in Prague and serves a global customer base. Why: The acquisition strengthens eM Client’s leadership in the email client industry and brings its powerful tools to more users. eM Client has established itself as a top choice for email users, integrating email, calendars, contacts, tasks, and notes

Aachen, Germany, 22 October 2024 – Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the pharmacokinetic characteristics of the compound after single and multiple ascending doses. The results of the trial are expected in Q3 2025. “Grünenthal pioneered the research into NOP receptor agonists to deliver a unique and transformative first-in-class therapy option to millions of patients suffering from chronic pain,” says Gillian Burgess, Head of Research, Grünenthal. “With a unique mechanism of action for treating chronic pain, these molecules have the potential to deliver robust pain relief combined with an improved safety profile compared to the available standard of care.” Pre-clinical data show that NOP receptor agonists have the potential to act as pot

Munich, 21 October 2024 Munich-based energy start-up PIONIERKRAFT has raised a high seven-figure amount in its Series A financing round, led by First Imagine!, a European venture capital firm focused on innovative solutions for a sustainable future. With this investment, PIONIERKRAFT will expand its energy-sharing solution for apartment buildings. "When we founded PIONIERKRAFT in 2019, we saw an opportunity to build a foundation for the energy transition in small and medium-sized apartment buildings," says Andreas Eberhardt, CEO of PIONIERKRAFT. "This funding will help us scale our network of partners and ramp up mass production of our energy-sharing solution." First Imagine! recognizes PIONIERKRAFT's growth potential and aims to accelerate the renewable energy transition. "Partnering with PIONIERKRAFT allows us to address the large sector of multi-tenant buildings in Germany that has been excluded from rooftop solar installations," says Alexander Starchenko, Managing Partner of First

Los Angeles/DNA – With less than three weeks to go until the November 5 presidential election, a new analysis warns that declining democratic accountability in the US means the power of American people’s voice will be diminished.

At this year’s World Health Summit in Berlin, the WHO Youth Council presented its vision for healthier societies. The World Health Organization’s Youth Council is calling on policymakers to better leverage the potential of young people. The Bertelsmann Stiftung and major youth organizations support the initiative.

Martina Hefter has won the 20th German Book Prize with her novel “Hey guten Morgen, wie geht es dir?” (Klett-Cotta).

Pfäffikon/Switzerland, 14/10/2024 - European Marketing Distribution announces a new associate member: Lotte from South Korea, one of the most important players in the Asian markets, is cooperating with EMD with immediate effect. EMD is consistently continuing its dynamic development with the cooperation now agreed with the prominent new member Lotte. Founded in 1989, the trade alliance now represents and bundles the interests of 12 companies on three continents. EMD's central projects include international procurement of Private Label products as well as the introduction of its vast network of suppliers to its members worldwide.

Redwitz/Rodach Consolidation has taken place on the European market for WPC products. Naturinform acquires parts of the production facilities of the Finnish company UPM, which had announced its intention to withdraw from the production of decking boards. The German WPC specialist will continue the production of the Piazza Pro and One decking boards previously marketed by UPM. The agreement will come into effect from October 2024. Naturinform has announced that it will scrutinise the market opportunities resulting from this in the upcoming weeks and ensure the smooth supply of both products for customers. The company thus assumes a key role in the growing market segment of WPC decking boards. With the acquisition of the UPM product lines, Naturinform is specifically strengthening its commitment to the co-ex-decking boards – these are WPC decking boards with an additional coating, which guarantees an exceptionally high level of robustness. At the same time, the company is driving its own

Highlights: Google has certified P3 as an accredited partner in its Third-Party Lab (3PL) Vendor program that ensures Android Automotive Operating System (AAOS) compliance. P3 was selected as one of Google's certification partners for in-vehicle infotainment (IVI) in the new Android Automotive partner ecosystem. P3 Group is an international technology and software consulting company with over 28 years' experience supporting major players in the automotive industry.

Berlin, October 2, 2024 x-cardiac, a leader in AI-based medical devices for the prediction of postoperative complications after cardiac surgery, is pleased to announce the successful MDR (Medical Device Regulation) certification of its new x-cardiac-platform. This certification introduces a completely new generation of products offering state-of-the-art technologies to optimize patient care and safety. The x-cardiac-platform is an innovative tool in the field of digital biomarkers and is specifically designed to increase patient safety and treatment quality in critical situations. With the successful MDR certification, the platform fulfills the strictest European requirements for safety and performance and thus marks a significant milestone in medical technology. The new product generation includes two innovative plug-ins: x-c-bleeding and x-c-renal-injury. These plug-ins offer unprecedented support in the detection and treatment of bleeding and kidney damage after major heart surgery.

The world's leading global health conference begins on October 13

Hamburg, Germany - The Taicang Day event was held Thursday in the northern German city of Hamburg, with participants highlighting the broad prospects for continued win-win cooperation between China and Germany.

The sluggish rate of progress made in the energy transition is putting the goal of reducing greenhouse gas emissions to zero by the middle of the century at risk. A comparison of four European countries shows that Denmark and Norway are making significant strides in transitioning to renewable heating and electricity. Norway is also advancing quickly in the road transport sector. The UK and Germany continue to face several challenges.